Head-to-head · Value Score
CoreAge Rx vs Lean Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Lean Rx a 64. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLean Rx
#329 · Grade C · Watch List
Est. first month
From $266/mo (starting dose, compounded)
Save ~80% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 64 — an est. $99/mo first month, with no teaser step-up baked in. Lean Rx isn't out of it: Someone who wants three formulation choices and is not shopping on price.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Lean Rx |
|---|---|---|
| Value Score | 93 (A+) | 64 (C) |
| Est. first month | $99/mo | From $266/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~80% |
| Semaglutide | $99/mo | From $266/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $399/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Lean Rx
Lean Rx is a Sacramento-based telehealth technology platform offering compounded semaglutide from $266 and tirzepatide from $399, in injectable, sublingual and tablet form.
Why it's a deal
- Three formulations on one account - injectable, sublingual and tablet - which is broader than most programs here offer
- Both molecules are priced on the site rather than after an intake, with no hidden fees advertised
- A telehealth call with a licensed provider happens before anything is prescribed
The fine print
- $266 for semaglutide and $399 for tirzepatide both sit above the medians tracked here, at roughly $179 and $249
- Lean Rx describes itself as a technology platform rather than a healthcare provider, so the clinical relationship sits with a third party it does not name
- No published state availability list
- Compounded only, and no provider credentials are detailed on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Lean Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.